BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

946 related articles for article (PubMed ID: 31921628)

  • 1. Ping-Pong-Tumor and Host in Pancreatic Cancer Progression.
    Mu W; Wang Z; Zöller M
    Front Oncol; 2019; 9():1359. PubMed ID: 31921628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells.
    Wang H; Rana S; Giese N; Büchler MW; Zöller M
    Int J Cancer; 2013 Jul; 133(2):416-26. PubMed ID: 23338841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44v6-competent tumor exosomes promote motility, invasion and cancer-initiating cell marker expression in pancreatic and colorectal cancer cells.
    Wang Z; von Au A; Schnölzer M; Hackert T; Zöller M
    Oncotarget; 2016 Aug; 7(34):55409-55436. PubMed ID: 27419629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cancer-initiating cell exosome message transfer into noncancer-initiating cells: the importance of CD44v6 in reprogramming.
    Wang Z; Sun H; Provaznik J; Hackert T; Zöller M
    J Exp Clin Cancer Res; 2019 Mar; 38(1):132. PubMed ID: 30890157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pancreatic Cancer-Initiating Cell Marker CD44v6 Affects Transcription, Translation, and Signaling: Consequences for Exosome Composition and Delivery.
    Sun H; Rana S; Wang Z; Zhao K; Schnölzer M; Provaznik J; Hackert T; Lv Q; Zöller M
    J Oncol; 2019; 2019():3516973. PubMed ID: 31485223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic cancer stem cell markers and exosomes - the incentive push.
    Heiler S; Wang Z; Zöller M
    World J Gastroenterol; 2016 Jul; 22(26):5971-6007. PubMed ID: 27468191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes, metastases, and the miracle of cancer stem cell markers.
    Wang Z; Zöller M
    Cancer Metastasis Rev; 2019 Jun; 38(1-2):259-295. PubMed ID: 31030373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Claudin7-dependent exosome-promoted reprogramming of nonmetastasizing tumor cells.
    Kyuno D; Zhao K; Schnölzer M; Provaznik J; Hackert T; Zöller M
    Int J Cancer; 2019 Oct; 145(8):2182-2200. PubMed ID: 30945750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer.
    Xiao L; Erb U; Zhao K; Hackert T; Zöller M
    Oncoimmunology; 2017; 6(6):e1319044. PubMed ID: 28680753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.
    Madhavan B; Yue S; Galli U; Rana S; Gross W; Müller M; Giese NA; Kalthoff H; Becker T; Büchler MW; Zöller M
    Int J Cancer; 2015 Jun; 136(11):2616-27. PubMed ID: 25388097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression.
    Wang Z; Zhao K; Hackert T; Zöller M
    Front Cell Dev Biol; 2018; 6():97. PubMed ID: 30211160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outsmart tumor exosomes to steal the cancer initiating cell its niche.
    Thuma F; Zöller M
    Semin Cancer Biol; 2014 Oct; 28():39-50. PubMed ID: 24631836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Origin of Claudin7 in Early Tumor Endosomes Affects Exosome Assembly.
    Kyuno D; Bauer N; Schnölzer M; Provaznik J; Ryschich E; Hackert T; Zöller M
    Int J Biol Sci; 2019; 15(10):2224-2239. PubMed ID: 31592143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma.
    Daniel SK; Sullivan KM; Labadie KP; Pillarisetty VG
    Clin Transl Med; 2019 Apr; 8(1):10. PubMed ID: 30931508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
    Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
    PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tspan8 and Tspan8/CD151 knockout mice unravel the contribution of tumor and host exosomes to tumor progression.
    Zhao K; Wang Z; Hackert T; Pitzer C; Zöller M
    J Exp Clin Cancer Res; 2018 Dec; 37(1):312. PubMed ID: 30541597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.
    Bertolini G; D'Amico L; Moro M; Landoni E; Perego P; Miceli R; Gatti L; Andriani F; Wong D; Caserini R; Tortoreto M; Milione M; Ferracini R; Mariani L; Pastorino U; Roato I; Sozzi G; Roz L
    Cancer Res; 2015 Sep; 75(17):3636-49. PubMed ID: 26141860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes in Cancer Disease.
    Zöller M
    Methods Mol Biol; 2016; 1381():111-49. PubMed ID: 26667458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress and potential of exosome analysis for early pancreatic cancer detection.
    Erb U; Zöller M
    Expert Rev Mol Diagn; 2016 Jul; 16(7):757-67. PubMed ID: 27206554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sonic hedgehog paracrine signaling activates stromal cells to promote perineural invasion in pancreatic cancer.
    Li X; Wang Z; Ma Q; Xu Q; Liu H; Duan W; Lei J; Ma J; Wang X; Lv S; Han L; Li W; Guo J; Guo K; Zhang D; Wu E; Xie K
    Clin Cancer Res; 2014 Aug; 20(16):4326-38. PubMed ID: 24947933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.